ANZACT was initially developed under the auspice of the Clinical Trials Council of the Cardiac Society of Australia and New Zealand (CSANZ), who supported a workshop to explore the barriers to establishing a collaborative network for cardiovascular clinical trials in 2016. An Interim Steering Committee was formed, two more workshops verified a continuing high level of interest and ANZACT’s first members were formally registered in February 2018.
Message from the Founding Chair
Professor Chris Reid
Cardiovascular Epidemiologist, Curtin University (WA) & Monash University (VIC)
I’m Chris Reid, John Curtin Distinguished Professor and Director of the Centres for Clinical Research and Education at Curtin and Monash Universities. With my colleagues, we led the development of ANZACT because we believe a clinical trials network will support investigators, nurture new researchers, and most importantly optimise the use of clinical trial and registry data to improve outcomes for people accessing cardiovascular health services.
The Medical Research Future Fund has included clinical trial networks (and clinical quality registries) as priorities in its strategic plan so the timing was right to pursue a formal cardiovascular trial network – and join the other 40+ discipline-specific networks in Australia.